Issue Price
₹84
Per Share
GMP
NIL
Grey Market
Est. Listing
₹84
Expected Price
Min. Application
₹268,800
2 lots × 1600 shares
Incorporated in 2019, Saroja Pharma Industries India Limited is engaged in trading, exporting and supplying Specialty Chemicals & API.The company deals in three types of product categories:1. Chemical, 2. Pharma Intermediary and 3. Veterinary Pharma API. The company supplies products such as Liquide Bromine, which is used as an agro-intermediate, Ethyl Acetate, which is used as an API solvent, and other pharmaceuticals used for human and veterinary drugs, and some of them are API solvents.APIs, known as bulk drugs or bulk actives, are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients.The company exports products mainly in Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore etc.Competitive Strength:Experienced Promoters and Management TeamScalable Business ModelWide and diverse range of product offeringsDiversified business operations and revenue base
Saroja Pharma Industries India Ltd proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 54,400 | — | ₹0.46 Cr | — |
| TOTAL | 1,084,800 | 100.00% | ₹9.11 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹134,400 |
| Retail (Max) | 13 | 20,800 | ₹1,747,200 |
| sNII (Min) | 14 | 22,400 | ₹1,881,600 |
| bNII (Min) | 68 | 108,800 | ₹9,139,200 |
| Particulars | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Revenue from Operations | 5035.09 | 5595.67 | 3674.67 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 106.06 | 114.01 | 73.13 |
| Net Worth | 508.66 | 402.60 | 93.59 |
| Total Assets | 2133.99 | 1551.19 | 822.39 |
| Reserves & Surplus | 215.09 | 380.02 | 92.59 |
| Total Borrowings | 1018.86 | 613.88 | 301.77 |